MyPath tool to help postpartum women plan next pregnancy
Part of Mental health clinical trials.
This study tests a patient-centered tool (MyPath) that supports reproductive planning for women with substance use disorder during late pregnancy and right after delivery. The goal is to improve how you get guidance about future pregnancy choices and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are in one of these groups: pregnant at 22–37 weeks, or 0–9 days postpartum.
- You plan to deliver (or did deliver) at the study hospital location.
- You have a substance use disorder (opioid, stimulant, or other), confirmed in your diagnosis or medical records.
- You did not have a fetal or newborn death with this pregnancy.
- You are not currently in jail or prison (but probation or living in a treatment program is usually okay).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at ways to predict and reduce harmful outcomes for pregnant people with opioid use disorder (OUD) and their babies. It focuses on people who are already receiving ongoing medication treatment during pregnancy and will follow them around delivery at a specific hospital.
This trial tests a support program for mothers (pregnant or with young children) who are in residential substance use treatment. It aims to improve well-being, family stability, and child safety—especially when children are at risk or in out-of-home placement.
This study tests a preconception (before pregnancy) support program for incarcerated women who have used substances and could become pregnant. It may help improve health and planning before a future pregnancy.
This study tests a community-based support program (“patient navigation”) to help pregnant people with unmet social needs get the care they need. It includes support from early pregnancy through 12 months after delivery and may help if social needs are affecting your prenatal care.
This program aims to help mothers and young children get safer, better support services when substance use occurred during pregnancy. It may help connect you (or your child) to the right community resources and reduce risk of ongoing alcohol or drug exposure.
This study tests a team-based approach to help pregnant women with opioid use disorder get better support during pregnancy. It may improve care for mothers and babies.
Hear when a new Substance Use Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.